EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Distinct changes in plasma protein profiles of cancer patients receiving immune checkpoint inhibitors versus chemotherapy: implications for thrombosis risk and adverse outcomes

Eleonora Camilleri, Nikola Vladic, Cornelia Englisch, Daniel Steiner, Matthias Preusser, Anna S Berghoff, Thorsten Fuereder, Julia M Berger, L Renee Ruhaak, Suzanne C Cannegieter, Bart J M van Vlijmen, Frederikus A Klok und 1 weitere

Research and Practice in Thrombosis and Haemostasis · 2026

DOI: 10.1016/j.rpth.2026.106929 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Research and Practice in Thrombosis and Haemostasis, 2026. Verfasst von Eleonora Camilleri und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Thrombosis, Blood Proteins, Carcinoma, Non-Small-Cell Lung. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Horizon Europe.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsThrombosisBlood ProteinsCarcinoma, Non-Small-Cell LungHead and Neck NeoplasmsLung NeoplasmsAntineoplastic AgentsHumansFemaleMaleMiddle AgedAgedRisk FactorsTreatment Outcome

Stichwörter der Autor:innen

blood coagulationcancerchemotherapyimmune checkpoint inhibitorsvenous thrombosis

Substanzen

Immune Checkpoint InhibitorsBlood ProteinsAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • Christian Doppler Laboratory for Personalized Immunotherapy, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, The Netherlands.
  • Division of Thrombosis and Hemostasis, Department of Medicine, Leiden University Medical Center, Leiden, The Netherlands.

Förderung

  • Horizon Europe

Zitieren

APA

Camilleri, E., Vladic, N., Englisch, C., Steiner, D., Preusser, M., Berghoff, A. S., Fuereder, T., Berger, J. M., Ruhaak, L. R., Cannegieter, S. C., van Vlijmen, B. J. M., Klok, F. A., & Ay, C. (2026). Distinct changes in plasma protein profiles of cancer patients receiving immune checkpoint inhibitors versus chemotherapy: implications for thrombosis risk and adverse outcomes. Research and Practice in Thrombosis and Haemostasis. https://doi.org/10.1016/j.rpth.2026.106929

Vancouver

Camilleri E, Vladic N, Englisch C, Steiner D, Preusser M, Berghoff AS, et al. Distinct changes in plasma protein profiles of cancer patients receiving immune checkpoint inhibitors versus chemotherapy: implications for thrombosis risk and adverse outcomes. Research and Practice in Thrombosis and Haemostasis. 2026. doi:10.1016/j.rpth.2026.106929

BibTeX
@article{Camilleri2026,
  author = {Camilleri, Eleonora and Vladic, Nikola and Englisch, Cornelia and Steiner, Daniel and Preusser, Matthias and Berghoff, Anna S and Fuereder, Thorsten and Berger, Julia M and Ruhaak, L Renee and Cannegieter, Suzanne C and van Vlijmen, Bart J M and Klok, Frederikus A and Ay, Cihan},
  title = {Distinct changes in plasma protein profiles of cancer patients receiving immune checkpoint inhibitors versus chemotherapy: implications for thrombosis risk and adverse outcomes},
  journal = {Research and Practice in Thrombosis and Haemostasis},
  year = {2026},
  doi = {10.1016/j.rpth.2026.106929}
}
Kostenlos starten →